Therapeutic Asset Ratings
373 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Meperidine
Pancreatic Cancer
National University of Malaysia
P4
B
(58)
METRONIDAZOLE
Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
P4
B
(58)
MIDAZOLAM
Pancreatic Cancer
National University of Malaysia
P4
B
(58)
Ivonescimab
Pancreatic Cancer
Akeso
P3
B
(58)
Sorafenib
Pancreatic Cancer
Medical College of Wisconsin
P3
B
(58)
Carboplatin
Pancreatic Cancer
Jinling Hospital, China
P2
B
(58)
Fludarabine
Pancreatic Cancer
National Cancer Institute (NCI)
P2
B
(58)
Inno-206
Pancreatic Cancer
Northwell Health
P2
B
(58)
Enoxaparin
Pancreatic Cancer
Helsinki University Central Hospital
P4
B
(57)
ROPIVACAINE
Pancreatic Cancer
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
P4
B
(57)
ETOPOSIDE
Pancreatic Cancer
Jinling Hospital, China
P2
B
(57)
Ipilimumab
Pancreatic Cancer
Shandong Cancer Hospital and Institute
P2
B
(57)
Ciprofloxacin
Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
P4
B
(56)
Pancrelipase
Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
P4
B
(56)
Pasireotide
Pancreatic Cancer
Helsinki University Central Hospital
P4
B
(56)
Durvalumab
Pancreatic Cancer
AHS Cancer Control Alberta
P2
B
(56)
Hydroxychloroquine
Pancreatic Cancer
Cancer Trials Ireland
P2
B
(56)
Pyrotinib
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P2
B
(56)
rc48-adc
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
P2
B
(56)
MITOMYCIN C
Pancreatic Cancer
Hirschfeld Oncology
P3
CCC
(55)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Pancreatic Cancer
AHS Cancer Control Alberta
P2
CCC
(55)
su011248
Pancreatic Cancer
National Cancer Institute (NCI)
P2
CCC
(55)
TIL
Pancreatic Cancer
Intima Bioscience, Inc.
P2
CCC
(55)
CEFUROXIME
Pancreatic Cancer
Leiden University Medical Center
P4
CCC
(54)
SUFENTANYL
Pancreatic Cancer
Peking University First Hospital
P4
CCC
(54)
Showing 26 to 50 of 373 assets
Previous
Page 2 of 15
Next